258 related articles for article (PubMed ID: 15389871)
21. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.
Zachos TA; Shields KM; Bertone AL
J Orthop Res; 2006 Jun; 24(6):1279-91. PubMed ID: 16649180
[TBL] [Abstract][Full Text] [Related]
22. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
23. The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells.
Corpataux JM; Naik J; Porter KE; London NJ
J Surg Res; 2005 Nov; 129(1):52-6. PubMed ID: 16087194
[TBL] [Abstract][Full Text] [Related]
24. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering.
Hughes AD
J Hum Hypertens; 1996 Jun; 10(6):387-90. PubMed ID: 8872802
[TBL] [Abstract][Full Text] [Related]
25. Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells.
Hoffmann A; Pelled G; Turgeman G; Eberle P; Zilberman Y; Shinar H; Keinan-Adamsky K; Winkel A; Shahab S; Navon G; Gross G; Gazit D
J Clin Invest; 2006 Apr; 116(4):940-52. PubMed ID: 16585960
[TBL] [Abstract][Full Text] [Related]
26. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.
Tanaka T; Porter CM; Horvath-Arcidiacono JA; Bloom ET
Int Immunol; 2007 Feb; 19(2):163-73. PubMed ID: 17182966
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human bone morphogenetic protein-2 promotes the proliferation of mesenchymal stem cells in vivo and in vitro.
Liu SB; Hu PZ; Hou Y; Li P; Cao W; Tian Q
Chin Med J (Engl); 2009 Apr; 122(7):839-43. PubMed ID: 19493400
[TBL] [Abstract][Full Text] [Related]
28. Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level.
Fujimoto M; Oka T; Murata T; Hori M; Ozaki H
Eur J Pharmacol; 2009 Jan; 602(2-3):432-8. PubMed ID: 19059394
[TBL] [Abstract][Full Text] [Related]
29. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels.
Nöth U; Rackwitz L; Heymer A; Weber M; Baumann B; Steinert A; Schütze N; Jakob F; Eulert J
J Biomed Mater Res A; 2007 Dec; 83(3):626-35. PubMed ID: 17503531
[TBL] [Abstract][Full Text] [Related]
30. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
Dansette PM; Jaoen M; Pons C
Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
[TBL] [Abstract][Full Text] [Related]
32. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
Yoneda T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
[No Abstract] [Full Text] [Related]
33. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
34. The role of noggin in human mesenchymal stem cell differentiation.
Rifas L
J Cell Biochem; 2007 Mar; 100(4):824-34. PubMed ID: 17133353
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture.
Vacanti V; Kong E; Suzuki G; Sato K; Canty JM; Lee T
J Cell Physiol; 2005 Nov; 205(2):194-201. PubMed ID: 15880640
[TBL] [Abstract][Full Text] [Related]
36. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
Sivaprasad U; Abbas T; Dutta A
Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
[TBL] [Abstract][Full Text] [Related]
37. Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma.
Sekiya I; Larson BL; Vuoristo JT; Reger RL; Prockop DJ
Cell Tissue Res; 2005 May; 320(2):269-76. PubMed ID: 15778851
[TBL] [Abstract][Full Text] [Related]
38. Protein aggregate-containing neuron-like cells are differentiated from bone marrow mesenchymal stem cells from mice with neurofilament light subunit gene deficiency.
Chao YX; He BP; Cao Q; Tay SS
Neurosci Lett; 2007 May; 417(3):240-5. PubMed ID: 17395374
[TBL] [Abstract][Full Text] [Related]
39. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
